Regeneron and Sanofi's Dupixent achieves positive Phase 3 results for chronic spontaneous urticaria, meeting key endpoints.
Leo Kryss, co-founder of Brazilian toy company Tectoy, has filed a lawsuit against real estate brokerage Douglas Elliman over ...
According to Benzinga Pro, KBR's peer group average for short interest as a percentage of float is 2.82%, which means the ...
In a positive development for the threatened hemp industry in Italy, the Regional Administrative Court of Lazio temporarily ...
Vera Bradley's Q2 earnings and revenues miss estimates, hurt by persistent macro headwinds, leading to a sharp drop in shares and a lowered FY25 outlook.
Texas Instruments's TXN short percent of float has risen 3.24% since its last report. The company recently reported that it ...
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An ...
Bumble (NASDAQ: BMBL) plans to use AI to improve user experience and compete with Tinder. Launching new tools by winter to ...
Novo Nordisk presented data on its next-generation weight-loss candidate, amycretin, which showed a significant 13% weight ...
Johnson & Johnson announced promising Phase 2 SKIPPirr study results for Rybrevant in reducing infusion-related reactions in ...
Piper Sandler cut Supernus Pharmaceuticals, Inc. SUPN price target from $41 to $36. Piper Sandler analyst David Amsellem ...
The London-listed cannabis-focused pharma company Celadon Pharmaceuticals raised £1.05 million ($1.37 million). Celadon also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results